Interactome Changes Quantified to Identify the ER Proteostasis Network to Fight Amyloid Diseases

Area of Science:

• Molecular Biology
• Proteomics
• Cell Biology

Background:

• Amyloid diseases are characterized by the accumulation of misfolded amyloid proteins.
• The secretion of amyloidogenic proteins is a key step in amyloid formation.
• Understanding the regulatory mechanisms controlling this secretion is crucial for therapeutic intervention.

Purpose of the Study:

• To elucidate the molecular mechanism by which ATF6 activation impacts amyloidogenic protein secretion.
• To identify potential therapeutic targets for preventing amyloid formation.

Main Methods:

• Quantitative interactome proteomics was employed to analyze protein interactions.
• Cellular models were used to study the effects of ATF6 activation.

Main Results:

• ATF6 activation was shown to reduce the secretion of specific amyloidogenic proteins.
• The study identified key molecular players involved in this ATF6-mediated regulation.

Conclusions:

• ATF6 activation represents a promising therapeutic strategy for mitigating amyloidogenesis.
• Targeting the ATF6 pathway could offer a novel approach for treating amyloid-related disorders.